Navigation Links
BioAmber Issues Statement Required by Section 610(b) of the NYSE MKT Company Guide
Date:3/16/2017

MONTREAL, March 16, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA), today announced that its audited consolidated financial statements for the fiscal year ended December 31, 2016, which were included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2017, contained a going concern qualification from its registered independent public accounting firm. This announcement is made in accordance with NYSE MKT Company Guide Section 610(b), which requires separate disclosure of receipt of an audit opinion containing a going concern qualification. This announcement does not represent any change or amendment to the Company's audited financial statements or to its Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

About BioAmber
BioAmber (NYSE: BIOA) is a renewable materials company. Its innovative technology platform combines biotechnology and catalysis to convert renewable feedstock into building block materials that are used in a wide variety of everyday products including plastics, paints, textiles, food additives and personal care products. For more information visit www.bio-amber.com


'/>"/>
SOURCE BioAmber Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. BioAmber Announces Webcast of Fiscal Fourth Quarter And Full 2016 Financial Results
2. BioAmber CEO steps down, current COO Fabrice Orecchioni named President
3. BioAmber announces reimbursement of corporate debt and closing of public offering
4. BioAmber Inc. increases previously announced public offering to US$17.5 million
5. BioAmber Inc. announces US $10 million underwritten public offering
6. BioAmber Inc. announces $7 million underwritten offering of common stock and concurrent $8.9 million registered direct offering of warrants
7. BioAmber and CJ CheilJedang Plan JV for Succinic Acid Production in Asia
8. DuPont Tate & Lyle Bio Products and BioAmber Launch New Sampling Program at UTECH NA
9. BioAmber Announces Year End Operational and Financial Results for 2015
10. BioAmber Announces Webcast of Fiscal Fourth Quarter and Full 2015 Financial Results
11. BioAmber Announces Changes to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... WonderWorks, Myrtle Beach’s science focused amusement ... of deep space exploration and inspire space enthusiasts. The exhibit features interactive exhibits ... guest appearance by former Shuttle Astronaut Don Thomas. , The intergalactic weekend kicks ...
(Date:4/26/2017)... ... April 26, 2017 , ... As the call ... healthcare industry stakeholders, the discussion surrounding the topic will continue at WEDI 2017- ... in Los Angeles, Calif. Hosted by the Workgroup for Electronic Data Interchange (WEDI), ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
(Date:4/24/2017)... , April 24, 2017  Dante Labs announced today the ... EUR 850 (ca. $900). While American individuals have been able ... time Europeans can access WGS below EUR 1,000. ... to leveraging genetic information to make informed decisions about disease ... ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):